[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367719-105":59,"doc-detail-367719-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rbm10-inhibits-pancreatic-cancer-development-by-suppressing-immune-escape-through-pd-1-expression","RBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression","","RNA-binding motif protein-10 (RBM10) is implicated in pancreatic adenocarcinoma, yet its mechanism in immune regulation is not well defined. This study evaluates RBM10 levels in PAAD tissues using Western blotting, RT-qPCR, and immunohistochemistry, linking reduced RBM10 in tumors to enhanced proliferation, migration, and colony formation after RBM10 knockdown. Bioinformatics and pathway analyses support JAK-STAT signaling involvement. Functionally, RBM10 loss elevates PD-1 in natural killer cells and weakens tumor-killing, while the JAK inhibitor AZD1480 restores NK cytotoxicity. High RBM10 predicts favorable prognosis and suggests RBM10 suppresses immune escape via JAK-STAT-mediated PD-1 regulation in NK cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rbm10-inhibits-pancreatic-cancer-development-by-suppressing-immune-escape-through-pd-1-expression/367719/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rbm10-inhibits-pancreatic-cancer-development-by-suppressing-immune-escape-through-pd-1-expression/367719.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research focus of the study?","Question",{"text":112,"@type":113},"The study examines how RBM10 regulates pancreatic cancer progression and immune responses, with emphasis on PD-1 expression in natural killer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was RBM10 expression measured in pancreatic tissues?",{"text":117,"@type":113},"RBM10 expression was assessed using Western blotting, RT-qPCR, and immunohistochemistry in PAAD patient tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens to NK cell function when RBM10 is deficient?",{"text":121,"@type":113},"RBM10 deficiency increases PD-1 expression in NK cells in vitro and reduces their tumor-killing ability; NK cytotoxicity is restored by the JAK pathway inhibitor AZD1480.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367719,1790688011,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2025; 16(10): 3080-3093. doi: 10.7150/jca.111459  \nResearch Paper  \nRBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression  \nXia Gao1,3\\#, Xiuqin Zhang2\\#, Junjie Huang1, Zhenyu Tan2, Jing Yang1, Liuhong Yuan2, Pengjun Wang1, Feier Chen2, Huiyan Wu2, Changyi Feng1, Hong Yu4,5􀀍, Shisan Bao1􀀍, Da Fu2,3􀀍, Kun Tao1,2􀀍  \n1. Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.  \n2. Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.  \n3. Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.  \n4. Department of Pathology, The Affiliated Taizhou Peoples Hospital of Nanjing Medical University, Taizhou 225300, Jiangsu, China.  \n5. Department of Pathology, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou 225300, Jiangsu, China.  \n\\# Equal contribution.  \n􀀍 Corresponding authors: Kun Tao ([taokun20119@163.com](taokun20119@163.com)), Da Fu ([fd12374@rjh.com.cn](fd12374@rjh.com.cn)), Shisan Bao ([profbao@homtail.com](profbao@homtail.com)), Hong Yu ([yuhong@njmu.edu.cn](yuhong@njmu.edu.cn)).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.02.03; Accepted: 2025.06.21; Published: 2025.07.04  \nAbstract  \nRNA-binding motif protein-10 (RBM10) plays a role in pancreatic adenocarcinoma (PAAD), though its precise underlying mechanism remains unclear. The current study investigates the role of RBM10 in pancreatic cancer progression and immune regulation.  \nRBM10 expression in pancreatic tissues from PAAD patient was assessed using Western blotting, RT-qPCR, and immunohistochemistry, revealing lower levels in pancreatic cancerous tissues compared to adjacent non-cancerous tissues. This finding aligns with in vitro experiments where RBM10 knockdown in pancreatic cancer cells enhanced colony formation, migration, and proliferation, which correlated with increased P-JAK1, P-JAK2, and P-STAT3 levels. Bioinformatics identified RBM10-related pathways and immune changes. Moreover, RBM10 deficiency in cancer cells increased PD-1 expression in natural killer cells in vitro, reducing their tumour-killing ability. However, treatment with the JAK pathway inhibitor AZD1480 restored NK cell cytotoxicity against cancer cells.  \nFinally, high RBM10 expression was associated with a favourable prognosis in pancreatic cancer patients, suggesting that RBM10 inhibits pancreatic cancer progression by suppressing tumour immune escape through JAK-STAT-mediated regulation of PD-1 expression in NK cells. This finding offers potential for the development of novel precision-targeted therapies in the management of pancreatic cancer.  \nKeywords: PAAD; RBM10; JAK-STAT; PD-1; NK cell.  \nIntroduction  \nPancreatic cancer is a highly fatal disease with a poor 5-year survival rate, making it the second leading cause of cancer-related deaths, despite its relatively low incidence [1] . It often presents with ambiguous symptoms, making early diagnosis challenging. This is partly due to the lack of obvious symptoms and the absence of reliable diagnostic markers with high sensitivity and specificity [2] .  \nCurrent management of pancreatic cancer includes surgery, radiotherapy and immunotherapy [3]. Surgery remains the only potential cure, but only  \n20% of patients are eligible for surgical intervention with reasonably good outcomes, though the risk of recurrence remains extremely high [2, 4] . More recently, advances in molecular biology have provided insig","cbCaidTi5crk90Z2","https://ap.wps.com/l/cbCaidTi5crk90Z2","pdf",7639141,14,"English","# Abstract\n# Introduction\n## Background and clinical challenge in pancreatic cancer\n## Roles of RNA-binding proteins and RBM family in cancer\n## Prior knowledge of RBM10 in cancer biology","[{\"question\":\"What is the main research focus of the study?\",\"answer\":\"The study examines how RBM10 regulates pancreatic cancer progression and immune responses, with emphasis on PD-1 expression in natural killer cells.\"},{\"question\":\"How was RBM10 expression measured in pancreatic tissues?\",\"answer\":\"RBM10 expression was assessed using Western blotting, RT-qPCR, and immunohistochemistry in PAAD patient tissues.\"},{\"question\":\"What happens to NK cell function when RBM10 is deficient?\",\"answer\":\"RBM10 deficiency increases PD-1 expression in NK cells in vitro and reduces their tumor-killing ability; NK cytotoxicity is restored by the JAK pathway inhibitor AZD1480.\"}]","RBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression | PDF",1790172240,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c26640449e34af96f9549b0e270029c.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8a3398e5ca66652a347e46f615bddf2.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47fb8839617a27c9f81d39ff2ef480c4.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3db6ddc5fff58e624c91d8550091f9b3.webp",980,1268]